Source: Emerging Infectious Diseases (via Robert Wood Johnson Foundation)
From press release:
Hospitalizations related to methicillin-resistant Staphylococcus aureus (MRSA) infections more than doubled, from 127,000 to nearly 280,000, between 1999 and 2005, according to a new study in the December issue of the journal Emerging Infectious Diseases. During that same period, hospitalizations of patients with general staph infections increased 62 percent across the country.
Staph, or Staphylococcus aureus, are a kind of bacteria that attack wounds and cause life-threatening infections, such as blood poisoning and pneumonia. Methicillin-resistant S. aureus (MRSA) are “superbugs” that have evolved resistance to most commonly used antibiotics, so they are more difficult and expensive to treat.
The study, which is the first to examine the recent magnitude and trends related to staph and MRSA infections, found that such infections are now “endemic, and in some cases epidemic,” in many U.S. hospitals, long-term care facilities and communities. Study researchers say that control of the infection should be made a “national priority.”
Full Document (PDF; 192 KB)